End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.395 MYR | -2.47% | -1.25% | +9.72% |
05-01 | Glomac Unit Hit With Winding Up Petition Over Unpaid Debt | MT |
03-26 | Glomac Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company's share price in relation to its net book value makes it look relatively cheap.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Sector: Real Estate Development & Operations
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+9.72% | 63.96M | - | ||
+40.41% | 29.66B | B- | ||
-11.60% | 27.69B | B | ||
+7.86% | 27.57B | B- | ||
+20.90% | 26.07B | A- | ||
+49.25% | 24.02B | A- | ||
+13.23% | 21.83B | A | ||
-1.52% | 18.77B | B- | ||
+28.90% | 16.76B | B | ||
-13.27% | 15.28B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- GLOMAC Stock
- Ratings Glomac